Progyny, Inc. - Common Stock (NQ:PGNY)

27.83 +0.28 (+1.02%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

A Healthcare Debate: Progyny vs. Hims & Hers ↗

September 26, 2025

Motley Fool analysts take a look.

Via The Motley Fool

Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY)

September 15, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers.

Via StockStory

Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power

September 15, 2025

The U.S. financial markets are currently at a critical juncture, with the stability of the 10-year Treasury yield hovering steadfastly around the 4% mark. This apparent calm in long-term borrowing...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

The Analyst Verdict: Progyny In The Eyes Of 4 Experts ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

3 Profitable Stocks Walking a Fine Line

September 10, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Bond Yields Tumble as Investors Brace for Aggressive Fed Rate Cuts

September 08, 2025

U.S. Treasury yields have recently experienced a significant decline, with the benchmark 10-year Treasury note falling to its lowest levels since April 2025. This sharp dip in yields reflects a...

Via MarketMinute

Topics Bonds Economy Supply Chain

Why Progyny (PGNY) Stock Is Trading Lower Today

September 05, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 5.1% in the afternoon session after a broader market downturn triggered by a surprisingly weak U.S. labor market report. The decline was...

Via StockStory

Topics Artificial Intelligence

2 Small-Cap Stocks Worth Your Attention and 1 We Brush Off

September 01, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Progyny (PGNY) Stock Trades Up, Here Is Why

August 27, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the morning session after JPMorgan raised its price target on the company's stock. JPMorgan increased its price target to $25...

Via StockStory

A Glimpse Into The Expert Outlook On Progyny Through 5 Analysts ↗

August 26, 2025

Via Benzinga

3 Cash-Heavy Stocks with Questionable Fundamentals

August 22, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

1 Russell 2000 Stock with Impressive Fundamentals and 2 We Ignore

August 21, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

Progyny (PGNY) Stock Is Up, What You Need To Know

August 18, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the afternoon session after continued positive momentum as the company reported stronger-than-expected second-quarter results...

Via StockStory

Topics Economy

NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy

Progyny Inc (NASDAQ:PGNY) – A Prime Affordable Growth Stock with Strong Fundamentals and Fair Valuation ↗

August 13, 2025

Progyny (PGNY) offers strong growth potential with 38% revenue growth, 32% EPS outlook, and fair valuation (P/E 24.75). Debt-free with solid profitability, it aligns with the Affordable Growth strategy...

Via Chartmill

PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance

August 12, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s...

Via StockStory

1 Cash-Producing Stock with Promising Prospects and 2 We Ignore

August 11, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 07, 2025

Via Benzinga

Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic

August 07, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s...

Via StockStory

Progyny, Inc. Announces Second Quarter 2025 Results

August 07, 2025

From Progyny, Inc.

Via GlobeNewswire

Progyny Earnings: What To Look For From PGNY

August 05, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results this Thursday after market hours. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence Economy World Trade

PROGYNY INC (NASDAQ:PGNY) Stands Out as a High-Quality Buy-and-Hold Stock with Strong Growth and Financial Health ↗

August 05, 2025

The Caviar Cruise strategy identifies high-quality stocks like Progyny Inc (PGNY), excelling in revenue growth, ROIC, profit quality, and debt-free stability for long-term investors.

Via Chartmill

3 Low-Volatility Stocks We Think Twice About

August 04, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

New Progyny Study Reveals Gap Between Perceptions and Realities in Women’s Health Benefits Coverage

July 30, 2025

Increased awareness of expanded women’s health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings

From Progyny, Inc.

Via GlobeNewswire

Why Progyny (PGNY) Stock Is Up Today

July 21, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the afternoon session after the stock gained ground amid a broader market rally as investors looked ahead to a busy week of...

Via StockStory

Why Progyny (PGNY) Stock Is Falling Today

July 18, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 3.9% in the afternoon session after a regulatory filing revealed a significant institutional investor had sharply reduced its stake in...

Via StockStory

Topics Artificial Intelligence

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

July 10, 2025

From Progyny, Inc.

Via GlobeNewswire

1 Value Stock with Impressive Fundamentals and 2 to Turn Down

July 09, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Under the Radar: Hunting Smart in the Alleyway of Value and Growth ↗

July 08, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.